Ventilator associated pneumonia (VAP) accounts for the majority of nosocomial pneumonia which may lead to more extensive hospital stay and increased intensive care. Endrotachael tubes that provide continuous subglotic suctioning (abbreviated: CSS-ET Continue Reading...
oral chlorhexidine as preventative agent in of ventilator-associated pneumonia (VAP) in adults who are critically ill and mechanically ventilated in intensive care units (ICUs). The process of critiquing published studies leads to higher level of co Continue Reading...
pneumonia is a recurrent mechanical ventilation complication affecting almost 25% of ventilated patients. This type of pneumonia is referred to as ventilator-associated pneumonia (VAP) and it accounts for up to 90% of nosocomial infections among the Continue Reading...
Introduction Advances in medicine have resulted in the further enhancement of patient outcomes in healthcare settings. It is, however, important to note that the treatment of many patients in close proximity does have some downsides. Hospital acquire Continue Reading...
